Developing effective vaccine strategies to launch promising new generation vaccine candidates

At the upcoming World Vaccine Congress Asia 2013, Mr. Ysuyuki Ishii will be joining us as one of the many speakers. Hear about developing effective vaccine strategies to launch promising new generation vaccine candidates as Mr. Ishii introduces alpha-galactosylceramide (GalCer), a ligand for invariant natural killer T (iNKT) cells bridging between innate and adaptive immunity. He will also be presenting …